Design of Photocaged Puromycin for Nascent Polypeptide Release and Spatiotemporal Monitoring of Translation
The antibiotic puromycin, which inhibits protein translation, is used in a broad range of biochemical applications. The synthesis, characterization, and biological applications of NVOC‐puromycin, a photocaged derivative that is activated by UV illumination, are presented. The caged compound had no e...
Saved in:
Published in | Angewandte Chemie International Edition Vol. 54; no. 12; pp. 3717 - 3721 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
WILEY-VCH Verlag
16.03.2015
WILEY‐VCH Verlag Wiley Wiley Subscription Services, Inc |
Edition | International ed. in English |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The antibiotic puromycin, which inhibits protein translation, is used in a broad range of biochemical applications. The synthesis, characterization, and biological applications of NVOC‐puromycin, a photocaged derivative that is activated by UV illumination, are presented. The caged compound had no effect either on prokaryotic or eukaryotic translation or on the viability of HEK 293 cells. Furthermore, no significant release of ribosome‐bound polypeptide chains was detected in vitro. Upon illumination, cytotoxic activity, in vitro translation inhibition, and polypeptide release triggered by the uncaging of NVOC‐puromycin were equivalent to those of the commercial compound. The quantum yield of photolysis was determined to be 1.1±0.2 % and the NVOC‐puromycin was applied to the detection of newly translated proteins with remarkable spatiotemporal resolution by using two‐photon laser excitation, puromycin immunohistochemistry, and imaging in rat hippocampal neurons.
On like a light: The antibiotic puromycin (green) is a translation inhibitor that triggers the release of the nascent polypeptide chain (red) from the ribosome (yellow) and it is used in a number of applications. A photocaged puromycin derivative, NVOC‐puromycin, was synthesized and characterized. Both functional recovery upon UV illumination and biological inactivity in vitro and in vivo were demonstrated. |
---|---|
Bibliography: | DFG ArticleID:ANIE201410940 We thank E. Stirnal, B. Fürtig, F. Sochor, M. Strumpf, R. Silvers and C. Richter for support. This work was funded by the DFG in Collaborative Research Center SFB807 and the HFSP. H.S. and J.W. are members of the cluster of excellence: Macromolecular Complexes. istex:A43D6AEF16F3C9C1C5B49899C00E9F62C66B2E70 ark:/67375/WNG-1H6KWFGD-0 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1433-7851 1521-3773 |
DOI: | 10.1002/anie.201410940 |